Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve awareness of the potential impact of Group B Strep on (a) pregnant women and (b) newborn children.

Practitioners are expected to take a risk-based approach to the screening, diagnosis, and treatment of group B streptococcus (GBS). Under current National Institute for Health and Care Excellence guidance, pregnant women who are known to carry GBS, or who have risk factors such as a previous baby with GBS infection or fever during labour, should be offered antibiotics during labour to help prevent early-onset infection in their baby.

To improve understanding, prevention, and treatment of GBS infection, the Department is supporting a trial, funded by the National Institute for Health and Care Research. It aims to determine whether routine testing for GBS for all women, either in late pregnancy or on admission for labour with point of care testing, reduces early-onset neonatal sepsis compared to the current approach of risk-based screening. Findings from the trial will be submitted to the Department and reviewed by the UK National Screening Committee to inform future decisions on national screening policy.